메뉴 건너뛰기




Volumn 135, Issue 1, 2015, Pages 196-202

Eradicating polio: How the world's pediatricians can help stop this crippling illness forever

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED POLIOMYELITIS VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

EID: 84920367448     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-3163     Document Type: Article
Times cited : (20)

References (27)
  • 1
    • 84902054356 scopus 로고    scopus 로고
    • Poliovirus vaccine - Live
    • Plotkin SA, Orenstein WA, Offit PA, eds. 6th ed. Edinburgh, United Kingdom: Elsevier/Saunders
    • Sutter RW, Kew OM, Cochi SL, Aylward B. Poliovirus vaccine - live. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 6th ed. Edinburgh, United Kingdom: Elsevier/Saunders; 2013:598-645
    • (2013) Vaccines , pp. 598-645
    • Sutter, R.W.1    Kew, O.M.2    Cochi, S.L.3    Aylward, B.4
  • 2
    • 78649652084 scopus 로고    scopus 로고
    • From emergence to eradication: The epidemiology of poliomyelitis deconstructed
    • Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol. 2010;172(11):1213-1229
    • (2010) Am J Epidemiol , vol.172 , Issue.11 , pp. 1213-1229
    • Nathanson, N.1    Kew, O.M.2
  • 3
    • 84902042230 scopus 로고    scopus 로고
    • Poliovirus vaccine-inactivated
    • Plotkin SA, Orenstein WA, Offit PA, eds. 6th ed. Edinburgh, United Kingdom: Elsevier/Saunders
    • Vidor E, Plotkin SA. Poliovirus vaccine - inactivated. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 6th ed. Edinburgh, United Kingdom: Elsevier/Saunders; 2013:573-597
    • (2013) Vaccines , pp. 573-597
    • Vidor, E.1    Plotkin, S.A.2
  • 4
    • 84893419246 scopus 로고    scopus 로고
    • The final stages of the global eradication of poliomyelitis
    • Grassly NC. The final stages of the global eradication of poliomyelitis. Philos Trans R Soc Lond B Biol Sci. 2013;368(1623):1-14
    • (2013) Philos Trans R Soc Lond B Biol Sci , vol.368 , Issue.1623 , pp. 1-14
    • Grassly, N.C.1
  • 5
    • 70349314774 scopus 로고    scopus 로고
    • Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India
    • Grassly NC, Jafari H, Bahl S, et al. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J Infect Dis. 2009;200(5):794-801
    • (2009) J Infect Dis , vol.200 , Issue.5 , pp. 794-801
    • Grassly, N.C.1    Jafari, H.2    Bahl, S.3
  • 6
    • 0026075384 scopus 로고
    • Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review
    • Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis. 1991;13(5):926-939
    • (1991) Rev Infect Dis , vol.13 , Issue.5 , pp. 926-939
    • Patriarca, P.A.1    Wright, P.F.2    John, T.J.3
  • 8
    • 84889827278 scopus 로고    scopus 로고
    • No country is safe without global eradication of poliomyelitis
    • Mundel T, Orenstein WA. No country is safe without global eradication of poliomyelitis. N Engl J Med. 2013;369(21): 2045-2046
    • (2013) N Engl J Med , vol.369 , Issue.21 , pp. 2045-2046
    • Mundel, T.1    Orenstein, W.A.2
  • 10
    • 68249085566 scopus 로고    scopus 로고
    • Achieving polio eradication: A review of health communication evidence and lessons learned in India and Pakistan
    • Obregón R, Chitnis K, Morry C, et al. Achieving polio eradication: a review of health communication evidence and lessons learned in India and Pakistan. Bull World Health Organ. 2009;87(8):624-630
    • (2009) Bull World Health Organ , vol.87 , Issue.8 , pp. 624-630
    • Obregón, R.1    Chitnis, K.2    Morry, C.3
  • 11
    • 84859509025 scopus 로고    scopus 로고
    • The global polio eradication initiative: Lessons learned and prospects for success
    • Aylward B, Tangermann R. The global polio eradication initiative: lessons learned and prospects for success. Vaccine. 2011;29(suppl 4):D80-D85
    • (2011) Vaccine , vol.29 , pp. D80-D85
    • Aylward, B.1    Tangermann, R.2
  • 12
    • 79959291528 scopus 로고    scopus 로고
    • The polio endgame
    • Aylward B, Yamada T. The polio endgame. N Engl J Med. 2011;364(24):2273-2275
    • (2011) N Engl J Med , vol.364 , Issue.24 , pp. 2273-2275
    • Aylward, B.1    Yamada, T.2
  • 13
    • 0026527532 scopus 로고
    • Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease
    • Strebel PM, Sutter RW, Cochi SL, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis. 1992;14(2):568-579
    • (1992) Clin Infect Dis , vol.14 , Issue.2 , pp. 568-579
    • Strebel, P.M.1    Sutter, R.W.2    Cochi, S.L.3
  • 14
    • 78449268293 scopus 로고    scopus 로고
    • Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: A randomised, double-blind, controlled trial
    • Sutter RW, John TJ, Jain H, et al. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial. Lancet. 2010;376(9753):1682-1688
    • (2010) Lancet , vol.376 , Issue.9753 , pp. 1682-1688
    • Sutter, R.W.1    John, T.J.2    Jain, H.3
  • 15
    • 0842282010 scopus 로고    scopus 로고
    • Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003
    • Deshpande JM, Nadkarni SS, Siddiqui ZA. Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003. Indian J Med Res. 2003;118:217-223
    • (2003) Indian J Med Res. , vol.118 , pp. 217-223
    • Deshpande, J.M.1    Nadkarni, S.S.2    Siddiqui, Z.A.3
  • 16
    • 84920408668 scopus 로고    scopus 로고
    • IPV recommended for countries to mitigate risks and consequences associated with OPV2 withdrawal
    • Geneva, Switzerland: World Health Organization; November Accessed April 7, 2014
    • World Health Organization. IPV recommended for countries to mitigate risks and consequences associated with OPV2 withdrawal. SAGE November 2012 meeting documentation. Geneva, Switzerland: World Health Organization; November 2012. Available at: www.who.int/immunization/sage/meetings/2012/november/news-sage-ipv-opv-nov2012/en/. Accessed April 7, 2014
    • (2012) SAGE November 2012 Meeting Documentation
    • World Health Organization1
  • 17
    • 0025203093 scopus 로고
    • Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: Systemic and local immune responses
    • Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis. 1990;162(6):1291-1297
    • (1990) J Infect Dis , vol.162 , Issue.6 , pp. 1291-1297
    • Faden, H.1    Modlin, J.F.2    Thoms, M.L.3    McBean, A.M.4    Ferdon, M.B.5    Ogra, P.L.6
  • 18
    • 84856210551 scopus 로고    scopus 로고
    • Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: A communitybased, randomised controlled trial
    • Estívariz CF, Jafari H, Sutter RW, et al. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a communitybased, randomised controlled trial. Lancet Infect Dis. 2012;12(2):128-135
    • (2012) Lancet Infect Dis , vol.12 , Issue.2 , pp. 128-135
    • Estívariz, C.F.1    Jafari, H.2    Sutter, R.W.3
  • 19
    • 0027256751 scopus 로고
    • Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine
    • Moriniere BJ, van Loon FP, Rhodes PH, et al. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet. 1993;341(8860):1545-1550
    • (1993) Lancet , vol.341 , Issue.8860 , pp. 1545-1550
    • Moriniere, B.J.1    Van Loon, F.P.2    Rhodes, P.H.3
  • 20
    • 84887596608 scopus 로고    scopus 로고
    • Geneva, Switzerland: World Health Organization. Accessed April 7, 2014
    • Global Polio Eradication Initiative. Polio Eradication & Endgame Strategic Plan 2013-2018. Geneva, Switzerland: World Health Organization; 2013. Available at: www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/PEESP-EN-US.pdf. Accessed April 7, 2014
    • (2013) Polio Eradication & Endgame Strategic Plan 2013-2018
    • Global Polio Eradication Initiative1
  • 21
    • 84920506156 scopus 로고    scopus 로고
    • Geneva, Switzerland: World Health Organization; Accessed April 7, 2014
    • World Health Organization. 7th Meeting of the SAGE Polio Working Group: note for the record. Geneva, Switzerland: World Health Organization; 2013. Available at: www.who.int/immunization/sage/meetings/2013/november/3-SAGE-Note-for-the-Record-exec-summary.pdf. Accessed April 7, 2014
    • (2013) 7th Meeting of the SAGE Polio Working Group: Note for the Record
    • World Health Organization1
  • 22
    • 84875950812 scopus 로고    scopus 로고
    • Expert review on poliovirus immunity and transmission
    • Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, et al. Expert review on poliovirus immunity and transmission. Risk Anal. 2013;33(4):544-605
    • (2013) Risk Anal , vol.33 , Issue.4 , pp. 544-605
    • Duintjer Tebbens, R.J.1    Pallansch, M.A.2    Chumakov, K.M.3
  • 23
    • 78649717696 scopus 로고    scopus 로고
    • Economic analysis of the global polio eradication initiative
    • Duintjer Tebbens RJ, Pallansch MA, Cochi SL, et al. Economic analysis of the global polio eradication initiative. Vaccine. 2010; 29(2):334-343
    • (2010) Vaccine , vol.29 , Issue.2 , pp. 334-343
    • Duintjer Tebbens, R.J.1    Pallansch, M.A.2    Cochi, S.L.3
  • 24
    • 84878431775 scopus 로고    scopus 로고
    • Scientific Experts Against Polio. Scientific declaration on polio eradication
    • Bhutta ZA, Orenstein WA; Scientific Experts Against Polio. Scientific declaration on polio eradication. Vaccine. 2013;31(27):2850-2851
    • (2013) Vaccine , vol.31 , Issue.27 , pp. 2850-2851
    • Bhutta, Z.A.1    Orenstein, W.A.2
  • 25
    • 34247167109 scopus 로고    scopus 로고
    • Eradication versus control for poliomyelitis: An economic analysis
    • Thompson KM, Tebbens RJ. Eradication versus control for poliomyelitis: an economic analysis. Lancet. 2007; 369(9570):1363-1371
    • (2007) Lancet , vol.369 , Issue.9570 , pp. 1363-1371
    • Thompson, K.M.1    Tebbens, R.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.